Latest Breaking News On - Bruno silva santos - Page 2 : comparemela.com

Takeda Pharmaceutical Company Limited: Takeda to Acquire GammaDelta Therapeutics to Accelerate Development of Allogeneic ?dT Cell Therapies Addressing Solid Tumors

Acquisition expands Takeda's immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging gamma-delta T cells for the potential treatment of solid tumors and hematological

United statesUnited kingdomCity ofSarah jefferyChristopher arendtChris stammOliver nussbaumerTim hainesBruno silva santosAdrian haydayRitsuko nomuraPaolo paolettiKing college londonUniversity of lisbonSt thoma biomedical research centreTakeda pharmaceutical company limited

Abingworth portfolio company GammaDelta Therapeutics to be acquired by Takeda

/PRNewswire/ Abingworth, a leading international life sciences investor, announces its portfolio company GammaDelta Therapeutics is to be acquired by Takeda.

United statesUnited kingdomCity ofOliver nussbaumerEleanor perkinTim hainesBruno silva santosAdrian haydayPaolo paolettiPrnewswire abingworthKing college londonUniversity of lisbonSt thoma biomedical research centreCancer research united kingdom commercial partnershipsNational institute for health research guyTakeda pharmaceutical company limited

Abingworth portfolio company GammaDelta Therapeutics to be acquired by Takeda

LONDON, Oct. 27, 2021 /PRNewswire/ Abingworth, a leading international life sciences investor, announces its portfolio company GammaDelta Therapeutics is to be acquired by Takeda Pharmaceutical

United statesUnited kingdomCity ofOliver nussbaumerEleanor perkinTim hainesBruno silva santosAdrian haydayPaolo paolettiPrnewswire abingworthKing college londonUniversity of lisbonSt thoma biomedical research centreCancer research united kingdom commercial partnershipsNational institute for health research guyTakeda pharmaceutical company limited

GammaDelta Therapeutics initiates Phase 1 trial of GDX012

GammaDelta Therapeutics initiates Phase 1 trial of GDX012
selectscience.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from selectscience.net Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofOliver nussbaumerMichael koslowskiBruno silva santosAdrian haydayPaolo paolettiKing college londonUniversity of lisbonCancer research united kingdomGammadelta therapeutics ltdFrancis crick instituteTakeda pharmaceutical companyIndustry newsGammadelta therapeuticsDelta therapeutics

GammaDelta Therapeutics initiates first-in-human phase 1 trial of GDX012 for the treatment of acute myeloid leukemia

GammaDelta Therapeutics initiates first-in-human phase 1 trial of GDX012 for the treatment of acute myeloid leukemia
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofOliver nussbaumerMichael koslowskiBruno silva santosAdrian haydayPaolo paolettiKing college londonUniversity of lisbonCancer research united kingdomGammadelta therapeutics ltdFrancis crick instituteTakeda pharmaceutical companyGammadelta therapeuticsChief medical officerTakeda pharmaceutical company limited